PMC:7253482 / 172-398
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
26 | 16-20 | Species | denotes | CoVs | Tax:11118 |
33 | 195-200 | Gene | denotes | spike | Gene:43740568 |
41 | 26-34 | Disease | denotes | zoonotic | MESH:D015047 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 205-217 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 114-121 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focuses |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 205-217 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 35-44 | http://purl.obolibrary.org/obo/IDO_0000528 | denotes | pathogens |
T2 | 166-189 | http://purl.obolibrary.org/obo/GO_0006959 | denotes | humoral immune response |
T3 | 174-189 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T24 | 1-14 | NNS | denotes | coronaviruses |
T25 | 15-16 | -LRB- | denotes | ( |
T26 | 16-20 | NNS | denotes | CoVs |
T27 | 20-21 | -RRB- | denotes | ) |
T28 | 22-25 | VBP | denotes | are |
T29 | 26-34 | JJ | denotes | zoonotic |
T30 | 35-44 | NNS | denotes | pathogens |
T31 | 45-49 | IN | denotes | with |
T32 | 50-54 | JJ | denotes | high |
T33 | 55-63 | NN | denotes | fatality |
T34 | 64-69 | NNS | denotes | rates |
T35 | 70-73 | CC | denotes | and |
T36 | 74-82 | JJ | denotes | pandemic |
T37 | 83-92 | NN | denotes | potential |
T38 | 94-101 | NN | denotes | Vaccine |
T39 | 102-113 | NN | denotes | development |
T40 | 114-121 | VBZ | denotes | focuses |
T41 | 122-124 | IN | denotes | on |
T42 | 125-128 | DT | denotes | the |
T43 | 129-138 | JJ | denotes | principal |
T44 | 139-145 | NN | denotes | target |
T45 | 146-148 | IN | denotes | of |
T46 | 149-152 | DT | denotes | the |
T47 | 153-165 | VBG | denotes | neutralizing |
T48 | 166-173 | JJ | denotes | humoral |
T49 | 174-180 | JJ | denotes | immune |
T50 | 181-189 | NN | denotes | response |
T51 | 189-190 | -COMMA- | denotes | , |
T52 | 191-194 | DT | denotes | the |
T53 | 195-200 | NN | denotes | spike |
T54 | 201-202 | -LRB- | denotes | ( |
T55 | 202-203 | NN | denotes | S |
T56 | 203-204 | -RRB- | denotes | ) |
T57 | 205-217 | NN | denotes | glycoprotein |
R21 | T28 | T24 | arg1Of | are,coronaviruses |
R22 | T24 | T25 | arg1Of | coronaviruses,( |
R23 | T26 | T25 | arg2Of | CoVs,( |
R24 | T27 | T25 | arg3Of | ),( |
R26 | T30 | T28 | arg2Of | pathogens,are |
R27 | T30 | T29 | arg1Of | pathogens,zoonotic |
R28 | T30 | T31 | arg1Of | pathogens,with |
R29 | T35 | T31 | arg2Of | and,with |
R30 | T34 | T32 | arg1Of | rates,high |
R31 | T34 | T33 | arg1Of | rates,fatality |
R32 | T34 | T35 | arg1Of | rates,and |
R33 | T37 | T35 | arg2Of | potential,and |
R34 | T37 | T36 | arg1Of | potential,pandemic |
R35 | T39 | T38 | arg1Of | development,Vaccine |
R36 | T39 | T40 | arg1Of | development,focuses |
R37 | T40 | T41 | arg1Of | focuses,on |
R38 | T44 | T41 | arg2Of | target,on |
R39 | T44 | T42 | arg1Of | target,the |
R40 | T44 | T43 | arg1Of | target,principal |
R41 | T44 | T45 | arg1Of | target,of |
R42 | T50 | T45 | arg2Of | response,of |
R43 | T50 | T46 | arg1Of | response,the |
R44 | T50 | T47 | arg1Of | response,neutralizing |
R45 | T50 | T48 | arg1Of | response,humoral |
R46 | T50 | T49 | arg1Of | response,immune |
R47 | T50 | T51 | arg1Of | response,"," |
R48 | T57 | T51 | arg2Of | glycoprotein,"," |
R49 | T57 | T52 | arg1Of | glycoprotein,the |
R50 | T57 | T53 | arg1Of | glycoprotein,spike |
R51 | T53 | T54 | arg1Of | spike,( |
R52 | T55 | T54 | arg2Of | S,( |
R53 | T56 | T54 | arg3Of | ),( |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 205-217 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 205-217 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 94-218 | Sentence | denotes | Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
68 | 1-14 | Species | denotes | coronaviruses | Tax:11118 |
69 | 16-20 | Species | denotes | CoVs | Tax:11118 |
26 | 16-20 | Species | denotes | CoVs | Tax:11118 |
41 | 26-34 | Disease | denotes | zoonotic | MESH:D015047 |
33 | 195-200 | Gene | denotes | spike | Gene:43740568 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T1 | 201-217 | Protein | denotes | (S) glycoprotein | https://www.uniprot.org/uniprot/Q9QAS2|https://www.uniprot.org/uniprot/Q9QAR5|https://www.uniprot.org/uniprot/Q9QAQ8|https://www.uniprot.org/uniprot/Q9IW04|https://www.uniprot.org/uniprot/Q9IKD1|https://www.uniprot.org/uniprot/Q990M4|https://www.uniprot.org/uniprot/Q990M3|https://www.uniprot.org/uniprot/Q990M2|https://www.uniprot.org/uniprot/Q990M1|https://www.uniprot.org/uniprot/Q91AV1|https://www.uniprot.org/uniprot/Q91A26|https://www.uniprot.org/uniprot/Q8V436|https://www.uniprot.org/uniprot/Q8JSP8|https://www.uniprot.org/uniprot/Q8BB25|https://www.uniprot.org/uniprot/Q86623|https://www.uniprot.org/uniprot/Q85088|https://www.uniprot.org/uniprot/Q85087|https://www.uniprot.org/uniprot/Q80BV6|https://www.uniprot.org/uniprot/Q7TFB1|https://www.uniprot.org/uniprot/Q7TFA2|https://www.uniprot.org/uniprot/Q7TA19|https://www.uniprot.org/uniprot/Q7T6T3|https://www.uniprot.org/uniprot/Q7T696|https://www.uniprot.org/uniprot/Q77NC4|https://www.uniprot.org/uniprot/Q6TNF9|https://www.uniprot.org/uniprot/Q6R1L7|https://www.uniprot.org/uniprot/Q6QU82|https://www.uniprot.org/uniprot/Q6Q1S2|https://www.uniprot.org/uniprot/Q696Q6|https://www.uniprot.org/uniprot/Q66291|https://www.uniprot.org/uniprot/Q66290|https://www.uniprot.org/uniprot/Q66199|https://www.uniprot.org/uniprot/Q66177|https://www.uniprot.org/uniprot/Q66176|https://www.uniprot.org/uniprot/Q66174|https://www.uniprot.org/uniprot/Q65984|https://www.uniprot.org/uniprot/Q5MQD0|https://www.uniprot.org/uniprot/Q5I5X9|https://www.uniprot.org/uniprot/Q5DIY0|https://www.uniprot.org/uniprot/Q5DIX9|https://www.uniprot.org/uniprot/Q5DIX8|https://www.uniprot.org/uniprot/Q5DIX7|https://www.uniprot.org/uniprot/Q52PA3|https://www.uniprot.org/uniprot/Q4U5G0|https://www.uniprot.org/uniprot/Q3T8J0|https://www.uniprot.org/uniprot/Q3LZX1|https://www.uniprot.org/uniprot/Q3I5J5|https://www.uniprot.org/uniprot/Q14EB0|https://www.uniprot.org/uniprot/Q0ZME7|https://www.uniprot.org/uniprot/Q0Q4F2|https://www.uniprot.org/uniprot/Q0Q475|https://www.uniprot.org/uniprot/Q0Q466|https://www.uniprot.org/uniprot/Q0GNB8|https://www.uniprot.org/uniprot/Q02385|https://www.uniprot.org/uniprot/Q02167|https://www.uniprot.org/uniprot/Q01977|https://www.uniprot.org/uniprot/Q008X4|https://www.uniprot.org/uniprot/P89344|https://www.uniprot.org/uniprot/P89343|https://www.uniprot.org/uniprot/P89342|https://www.uniprot.org/uniprot/P59594|https://www.uniprot.org/uniprot/P36334|https://www.uniprot.org/uniprot/P36300|https://www.uniprot.org/uniprot/P33470|https://www.uniprot.org/uniprot/P30208|https://www.uniprot.org/uniprot/P30207|https://www.uniprot.org/uniprot/P30206|https://www.uniprot.org/uniprot/P30019|https://www.uniprot.org/uniprot/P27655|https://www.uniprot.org/uniprot/P25194|https://www.uniprot.org/uniprot/P25193|https://www.uniprot.org/uniprot/P25192|https://www.uniprot.org/uniprot/P25191|https://www.uniprot.org/uniprot/P25190|https://www.uniprot.org/uniprot/P24413|https://www.uniprot.org/uniprot/P23052|https://www.uniprot.org/uniprot/P22432|https://www.uniprot.org/uniprot/P18450|https://www.uniprot.org/uniprot/P17662|https://www.uniprot.org/uniprot/P15777|https://www.uniprot.org/uniprot/P15423|https://www.uniprot.org/uniprot/P12722|https://www.uniprot.org/uniprot/P12651|https://www.uniprot.org/uniprot/P12650|https://www.uniprot.org/uniprot/P11225|https://www.uniprot.org/uniprot/P11224|https://www.uniprot.org/uniprot/P11223|https://www.uniprot.org/uniprot/P10033|https://www.uniprot.org/uniprot/P0DTC2|https://www.uniprot.org/uniprot/P07946|https://www.uniprot.org/uniprot/P05135|https://www.uniprot.org/uniprot/P05134|https://www.uniprot.org/uniprot/O90304|https://www.uniprot.org/uniprot/O39227|https://www.uniprot.org/uniprot/K9N5Q8|https://www.uniprot.org/uniprot/A3EXG6|https://www.uniprot.org/uniprot/A3EXD0|https://www.uniprot.org/uniprot/A3EX94|https://www.uniprot.org/uniprot/Q4ZJS1 |
LitCovid-sample-PD-GO-BP-0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 166-189 | http://purl.obolibrary.org/obo/GO_0006959 | denotes | humoral immune response |
T3 | 174-189 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-sample-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 166-189 | http://purl.obolibrary.org/obo/GO_0006959 | denotes | humoral immune response |
T3 | 174-189 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 166-189 | http://purl.obolibrary.org/obo/GO_0006959 | denotes | humoral immune response |
T3 | 174-189 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 94-218 | Sentence | denotes | Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein. |